A recent Maxim article warned readers that masturbation may be harmful in the long wrong if they do it too often or the wrong way. Thankfully, the article is based on pseudoscience and misunderstandings—there is no reason to stop the activity.
We regularly learn about how research is progressing toward creating alternative forms of reversible contraception for men that include pills, shots, or other devices. Despite the flurry of excitement these news pieces generate, it seems we are still quite far from mass-marketed male birth control.
The report charges that same-gender sexual orientation and variations in gender identity and expression are “part of the normal spectrum of human diversity and do not constitute a mental disorder.”
Last week, 82 boy and girl Grissom High School students, ranging in age from freshmen to seniors, defied the dress code by wearing leggings, jeans with holes along the thigh, and tank tops in a “Stand Against the Dress Code” action.
The 2015 U.S. Trans Survey will build on the data collected by the 2011 National Transgender Discrimination Survey to provide a “360-degree view of trans lives.”
This week, a survey gives us insight into the sex lives of millennials, a study finds women engage in riskier sex on vacation, and advocates try another tactic for mandating condoms in porn.
One Utah program makes students choose to promise to uphold several flawed statements on abstinence. I would love to believe that the students would be brave enough to challenge what’s written on the page, but just in case, I decided to explain why some of the most outrageous statements just don’t make sense.
A group hopes to encourage affirmative consent by creating an app that asks partners to record each other saying “yes” before having sex—but it might just cause more problems than it solves.
This week, teens get health and sex information on the web, condom demonstrations are allowed in New York City public school health classes, and a British woman serves time for being too loud.
An FDA advisory panel recommended Thursday that the agency approve flibanserin, a drug that has often been called the female Viagra.